BioSpace News Archive

ViaLase, Inc today announced the online publication of 24-month safety data from the first-in-human study of femtosecond laser image-guided high-precision trabeculotomy (FLigHT) performed with the ViaLase technology in Ophthalmology® Science, a journal of the American Academy of Ophthalmology.

Medexus Pharmaceuticals is pleased to announce that company management will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference from April 25 to 26, 2023.

Gamida Cell Ltd. announced the launch of a follow-on public offering of its ordinary shares and accompanying warrants to purchase its ordinary shares.

TELA Bio, Inc. announced the pricing of its previously announced underwritten public offering of 4,750,000 shares of its common stock at a price to the public of $9.50 per share, for gross proceeds of $45.125 million, before deducting underwriting discounts and commissions and other estimated offering expenses.

Harvard Bioscience, Inc. announced the initial order for the Company’s new high-capacity behavioral monitoring system for pre-clinical applications.

Cipher Pharmaceuticals (TSX: CPH), a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor

ImmVira presented preclinical study results of CAR-T enabler oHSV product MVR-7011 through poster publication at the American Association for Cancer Research annual meeting.

Everest Medicines announced that it has signed a Memorandum of Understanding for a strategic partnership with a subsidiary of Shanghai Pharma, SPH Keyuan Xinhua Pharmaceutical Co., Ltd.

Cali Biosciences Co., Ltd. announced it has initiated Phase III studies of its core product, CPL-01, with dosing in hernia patients already begun and dosing in bunion patients scheduled to start next month.

Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Company”), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated